DUBLIN, March 17, 2020 /PRNewswire/ -- The "Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application ...

Pricing pressure due to reimbursement cuts and limited budgets along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market ...

Changes in healthcare economics are clearly having an impact on point-of-care (POC) diagnostic testing. Market demand for remote testing is driving companies to develop easy-to-use platforms versus ...

The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. As per the CDC (Centers for Disease ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

The point-of-care (PoC) market continues to gain traction as it is expected to reach a market valuation of US$77.8 billion by 2028 and growing at a compound annual growth rate of 9.4 per cent. PoC ...

The MarketWatch News Department was not involved in the creation of this content. The Point-of-Care Diagnostics market is driven by the increasing demand for rapid and accurate testing solutions, ...